IL1B and COVID-19: Evidence so far supports that pyroptosis and subsequent IL-1β signaling play an important role in mediating COVID-19 disease pathology and can contribute to COVID-19 disease severity through multiple mechanisms, including lung immunopathology, systemic inflammation, and thrombosis.